These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2287783

  • 21. Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.
    Smith JW, Kroker-Lobos MF, Lazo M, Rivera-Andrade A, Egner PA, Wedemeyer H, Torres O, Freedman ND, McGlynn KA, Guallar E, Groopman JD, Ramirez-Zea M.
    PLoS One; 2017; 12(12):e0189255. PubMed ID: 29236788
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries.
    Groopman JD, Kensler TW, Wild CP.
    Annu Rev Public Health; 2008; 29():187-203. PubMed ID: 17914931
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.
    Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu MH, Wu WP, Wang LW, Wang Q, Huang GT, Yang PM, Lee HS, Santella RM.
    Int J Cancer; 1996 Sep 04; 67(5):620-5. PubMed ID: 8782648
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Aflatoxin exposure in viral hepatitis patients in Turkey.
    Mizrak D, Engin B, Onder FO, Yener B, Bektaş M, Biyikli Z, Idilman R, Cinar K, Karayalçin K, Ersöz S, Karayalçin S, Ozden A, Yurdaydin C, Yazihan N, Ataoğlu H, Bozkaya H, Uzunalimoğlu O.
    Turk J Gastroenterol; 2009 Sep 04; 20(3):192-7. PubMed ID: 19821201
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA.
    Cancer Epidemiol Biomarkers Prev; 2001 Jun 04; 10(6):617-25. PubMed ID: 11401911
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dietary aflatoxins and human primary liver cancer.
    Peers FG, Linsell CA.
    Ann Nutr Aliment; 1977 Jun 04; 31(4-6):1005-17. PubMed ID: 613902
    [Abstract] [Full Text] [Related]

  • 38. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD, Wang JS, Scholl P.
    Can J Physiol Pharmacol; 1996 Feb 04; 74(2):203-9. PubMed ID: 8723033
    [Abstract] [Full Text] [Related]

  • 39. Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan.
    Hatch MC, Chen CJ, Levin B, Ji BT, Yang GY, Hsu SW, Wang LW, Hsieh LL, Santella RM.
    Int J Cancer; 1993 Jul 30; 54(6):931-4. PubMed ID: 8392983
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.